ABOS
Price
$2.73
Change
+$0.37 (+15.68%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
197.9M
43 days until earnings call
Intraday BUY SELL Signals
AVTX
Price
$18.87
Change
+$0.67 (+3.68%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
990.34M
25 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABOS vs AVTX

ABOS vs AVTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABOS vs. AVTX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and AVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2026
Stock price -- (ABOS: $2.74 vs. AVTX: $18.84)
Brand notoriety: ABOS and AVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 44% vs. AVTX: 45%
Market capitalization -- ABOS: $197.9M vs. AVTX: $990.34M
ABOS [@Biotechnology] is valued at $197.9M. AVTX’s [@Biotechnology] market capitalization is $990.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileAVTX’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • AVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, AVTX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while AVTX’s TA Score has 6 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 3 bearish.
  • AVTX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, both ABOS and AVTX are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а +23.98% price change this week, while AVTX (@Biotechnology) price change was +4.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.30%. For the same industry, the average monthly price growth was +5.93%, and the average quarterly price growth was +1921.84%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 17, 2026.

AVTX is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (+2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTX($990M) has a higher market cap than ABOS($198M). ABOS YTD gains are higher at: 29.858 vs. AVTX (3.744). AVTX has higher annual earnings (EBITDA): -78.93M vs. ABOS (-108.82M). ABOS has more cash in the bank: 128M vs. AVTX (82M). AVTX has less debt than ABOS: AVTX (328K) vs ABOS (31.2M). AVTX has higher revenues than ABOS: AVTX (59K) vs ABOS (0).
ABOSAVTXABOS / AVTX
Capitalization198M990M20%
EBITDA-108.82M-78.93M138%
Gain YTD29.8583.744797%
P/E RatioN/A2.30-
Revenue059K-
Total Cash128M82M156%
Total Debt31.2M328K9,512%
FUNDAMENTALS RATINGS
AVTX: Fundamental Ratings
AVTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSAVTX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 12 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 20 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signal:
Gain/Loss:
AVTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNCSX46.090.62
+1.36%
Franklin Natural Resources R6
MLPDX6.800.05
+0.74%
Invesco SteelPath MLP Income A
AMRMX64.650.40
+0.62%
American Funds American Mutual A
ATEYX154.16-0.15
-0.10%
AB Sustainable Global Thematic Advisor
ZVNIX43.81-0.75
-1.68%
Zevenbergen Growth Institutional

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CCXI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CCXI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+5.79%
CCXI - ABOS
48%
Loosely correlated
+11.96%
CELC - ABOS
44%
Loosely correlated
+3.31%
NKTX - ABOS
43%
Loosely correlated
+12.98%
RCKT - ABOS
40%
Loosely correlated
+9.09%
BCYC - ABOS
39%
Loosely correlated
+3.33%
More

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with DFTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then DFTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
+8.96%
DFTX - AVTX
37%
Loosely correlated
+1.82%
BEAM - AVTX
36%
Loosely correlated
+3.91%
BCYC - AVTX
36%
Loosely correlated
+3.33%
PGEN - AVTX
34%
Loosely correlated
+7.43%
ABOS - AVTX
33%
Poorly correlated
+5.79%
More